Klick Health taps former Razorfish exec for new chief brand strategy officer role

Klick Health chief brand strategy officer Carl Turner
Klick Health continues to add personnel. The latest is Carl Turner, the agency's first-ever chief brand strategy officer. (Alpha Stock Images)

Klick Health has hired veteran brand strategist Carl Turner for a newly created role aimed at elevating the strategy function at the agency. As Klick’s first chief brand strategy officer, Turner will helm the agency’s existing brand strategy group and work to grow and evolve it.

“As we continue to evolve the marriage of activation, brand strategy, creative and medical it was something we really wanted to lean into," Glenn Zujew, Klick’s executive vice president of creative and medical, said. "The role of a chief was born out of knowing we needed this to be a prominent role in the organization and we wanted to elevate the craft, but it also became obvious with the level that Carl was at that this was a perfect fit.”

RELATED: Klick goes on creative director hiring spree thanks to new business


De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools

Wednesday, July 8, 2020 | 11am EST / 8am PST

This webinar will describe strategies to mitigate risks, reduce attrition and help improve the quality and safety of your drug candidate.

Klick chose Turner after more than eight months of searching, Zujew said. He was most recently at Publicis Health’s Razorfish as managing partner and chief strategy officer and before that worked at Saatchi & Saatchi Wellness, Publicis Lifebrands, JWT, Commonground and Palio in a variety of brand strategy roles.

“All forms of strategy are really valued by our clients now and it’s about, 'how do you integrate those forms of strategy in ways that bring about new value for the client?' Our clients are clamoring for strategy,” Turner said.

He’s looking forward to working at the growing and entrepreneurial agency, which recorded double-digit growth last year and added new business in therapeutic areas including migraine, ADHD, women’s and men’s health and oncology.

RELATED: Klick Health spills its secrets in new pharma marketing playbook

“One of the great advantages of working at Klick is the cross fertilization that happens between all the disciplines,” Turner said, adding that, “The ability to work in an entrepreneurial fashion and influence each other with new ways of thinking is where the excitement comes from.”

Suggested Articles

Novartis and Civica Rx are patterning up to shore up supply of six key generic injectables used in acute care settings in hospitals.

EU health commissioner Stella Kyriakides reportedly spoke with Gilead execs to iron out a deal to secure remdesivir supply for 16 EU countries.

Under a $1.6 billion deal with the U.S. government, Novavax has pledged to start producing 100 million doses of a COVID-19 vaccine later this year.